Author response for 'Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor ( GCGR / GLP‐1R ) agonist BI 456906'
التفاصيل البيبلوغرافية
العنوان:
Author response for 'Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor ( GCGR / GLP‐1R ) agonist BI 456906'